Literature DB >> 8682

Multiple forms of monoamine oxidase: fact and artefact.

M D Houslay, K F Tipton.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 8682     DOI: 10.1016/0024-3205(76)90224-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  33 in total

1.  Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.

Authors:  D L Murphy; S Lipper; S Slater; D Shiling
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

2.  Platelet monoamine oxidase B activity in parkinsonian patients.

Authors:  U Bonuccelli; P Piccini; P Del Dotto; G M Pacifici; G U Corsini; A Muratorio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

3.  Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.

Authors:  A R Green; B D Mitchell; A F Tordoff; M B Youdim
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

4.  Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.

Authors:  M Koulu; M Scheinin; A Kaarttinen; J Kallio; K Pyykkö; J Vuorinen; R H Zimmer
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

5.  The active centers of monoamine oxidase types "A" and "B": binding with (14C)-clorgyline and (14C)-deprenyl.

Authors:  M B Youdim
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

6.  Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study.

Authors:  N B Mercuri; A Bonci; A Siniscalchi; A Stefani; P Calabresi; G Bernardi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.

Authors:  A Korn; B Wagner; E Moritz; J Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

8.  Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

9.  Inhibition of monoamine oxidase-A of rat brain by pyrethroids--an in vitro kinetic study.

Authors:  G V Rao; K S Rao
Journal:  Mol Cell Biochem       Date:  1993-07-21       Impact factor: 3.396

10.  Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.

Authors:  S Lenzen; H Nahrstedt; U Panten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.